Published Date: 16-Jun-2020
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report LAMEA Neurostimulation Devices Market, published by KBV research, the LAMEA Neurostimulation Devices Market would witness market growth of 13.5% CAGR during the forecast period (2020-2026).
The Brazil market dominated the LAMEA Deep Brain Stimulators Market by Country in 2019, thereby, achieving a market value of $45.2 million by 2026. The Argentina market would witness a CAGR of 14.1% during (2020 - 2026). Additionally, The UAE market is exhibiting a CAGR of 12.5% during (2020 - 2026).
The Pain Management market dominated the Saudi Arabia Neurostimulation Devices Market by Applications in 2019, growing at a CAGR of 13.3 % during the forecast period. The Hearing Loss market is exhibiting a CAGR of 13.1% during (2020 - 2026). Additionally, The Urinary Incontinence market is witnessing highest CAGR of 14.4% during (2020 - 2026).
The Spinal Cord Stimulators market dominated the South Africa Neurostimulation Devices Market by Devices in 2019, growing at a CAGR of 13.7 % during the forecast period. The Deep Brain Stimulators market would showcase a CAGR of 13.7% during (2020 - 2026). Additionally, The Other Devices market is expected to witness highest CAGR of 20.6% during (2020 - 2026).
Structural Insights: https://www.kbvresearch.com/lamea-neurostimulation-devices-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, Boston Scientific Corporation, Nevro Corporation, Medtronic PLC, NeuroSigma, Inc., Integer Holdings Corporation, LivaNova PLC, NeuroPace, Inc., Neuronetics, Inc., and Synapse BioMedical, Inc.
Unique Offerings from KBV Research